Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus plus methotrexate versus placebo plus methotrexate in new-onset rheumatoid arthritis
ChiCTR1900024261Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Methotrexate + placebo with Sirolimus + methotrexate (2 arms). Primary endpoints: ACR20, DAS28 and 1 more. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR1900024261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024261.